BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23334834)

  • 1. Molecular cloning, purification and functional implications of recombinant GST tagged hGMCSF cytokine.
    Chaubey N; Ghosh SS
    Appl Biochem Biotechnol; 2013 Mar; 169(5):1713-26. PubMed ID: 23334834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of recombinant human granulocyte colony stimulating factor (hGMCSF) immobilized onto silica nanoparticles.
    Vanitha S; Goswami U; Chaubey N; Ghosh SS; Sanpui P
    Biotechnol Lett; 2016 Feb; 38(2):243-9. PubMed ID: 26549378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and therapeutic implications of recombinant sFRP1.
    Ghoshal A; Ghosh SS
    Appl Biochem Biotechnol; 2015 Feb; 175(4):2087-103. PubMed ID: 25432334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single step intein-mediated purification of hGMCSF expressed in salt-inducible E. coli.
    Srinivasa Babu K; Muthukumaran T; Antony A; Prem Singh Samuel SD; Balamurali M; Murugan V; Meenakshisundaram S
    Biotechnol Lett; 2009 May; 31(5):659-64. PubMed ID: 19148582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning, recombinant expression and characterization of GMCSF from the rhesus monkey, Macaca mulatta.
    Tao Z; Yang H; Jia D; Wan L; Cheng J; Lu X
    Dev Comp Immunol; 2013 May; 40(1):69-77. PubMed ID: 23352624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, soluble expression and purification of high yield recombinant hGMCSF in Escherichia coli.
    Das KM; Banerjee S; Shekhar N; Damodaran K; Nair R; Somani S; Raiker VP; Jain S; Padmanabhan S
    Int J Mol Sci; 2011; 12(3):2064-76. PubMed ID: 21673940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, expression and bioactivity of feline granulocyte-macrophage colony-stimulating factor.
    Dunham SP; Bruce J
    Gene; 2004 May; 332():97-106. PubMed ID: 15145059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning, expression in Escherichia coli and production of bioactive homogeneous recombinant human granulocyte and macrophage colony stimulating factor.
    Schwanke RC; Renard G; Chies JM; Campos MM; Batista EL; Santos DS; Basso LA
    Int J Biol Macromol; 2009 Aug; 45(2):97-102. PubMed ID: 19389424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of recombinant human GMCSF from Pichia pastoris GS115--a progressive strategy for economic production.
    Srinivasa Babu K; Pulicherla KK; Antony A; Meenakshisundaram S
    Am J Ther; 2014; 21(6):462-9. PubMed ID: 24531404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning analysis of ferritin and the cisplatin-subunit for cancer cell apoptosis in Aplysia juliana hepatopancreas.
    Zhu B; Huang L; Huang HQ
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Aug; 156(2):95-103. PubMed ID: 22579997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of the GM-CSF and IL-3 receptor complexes.
    Lyne PD; Bamborough P; Duncan D; Richards WG
    Protein Sci; 1995 Oct; 4(10):2223-33. PubMed ID: 8535258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein.
    Ushio S; Namba M; Okura T; Hattori K; Nukada Y; Akita K; Tanabe F; Konishi K; Micallef M; Fujii M; Torigoe K; Tanimoto T; Fukuda S; Ikeda M; Okamura H; Kurimoto M
    J Immunol; 1996 Jun; 156(11):4274-9. PubMed ID: 8666798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Design of recombinant Escherichia coli strains, determining the secretory expression of artificial human granulocyte-macrophage colony-stimulating factor genes].
    Petrovskaia LE; Ruzin AV; Shingarova LN; Korobko VG
    Bioorg Khim; 1995 Nov; 21(11):845-54. PubMed ID: 8670310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies.
    Williams MD; Rostovtsev A; Narla RK; Uckun FM
    Protein Expr Purif; 1998 Jul; 13(2):210-21. PubMed ID: 9675065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.
    Penafuerte C; Bautista-Lopez N; Boulassel MR; Routy JP; Galipeau J
    Cancer Res; 2009 Dec; 69(23):9020-8. PubMed ID: 19920194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein.
    Wen Q; Ma L; Luo W; Zhou MQ; He D; Lin Y; Wu ZQ; He XW; Wang JF; Wang XN
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):41-8. PubMed ID: 17708750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.